Skip to main content

and
  1. No Access

    Article

    Newer Formulations of Risperidone: Remarks About Risperidone ISM®

    Lourdes Anta, Elena Mata, Lourdes Ochoa Díaz de Monasterioguren in CNS Drugs (2020)

  2. No Access

    Article

    Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?

    To determine the efficacy and safety data of aflibercept + FOLFIRI in wt RAS mCRC patients after progression to standard chemotherapy + anti-EGFR treatment.

    Ruth Vera, Elena Mata, Encarna González in International Journal of Colorectal Disease (2020)

  3. Article

    Open Access

    Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma

    Elena Mata, Sara Fernández, Aurora Astudillo, Rubén Fernández in Blood Cancer Journal (2019)

  4. No Access

    Article

    Complications from the primary tumour are not related with survival in patients with synchronous stage IV colorectal cancer receiving chemotherapy without primary tumour resection

    The aim of this study was to evaluate the rate of complications from the primary tumour (CPT) requiring surgical or endoscopic intervention during chemotherapy treatment in patients with incurable synchronous ...

    Javier Suárez, Gabriel Marín, Ruth Vera in International Journal of Colorectal Disease (2015)